MARIZYME INC Purchase Agreements

Form of Waiver and Consent, dated as of November 20, 2023, between Marizyme, Inc. and each investor identified on Appendix A to the Unit Purchase Agreement between Marizyme, Inc.... (Filed With SEC on November 21, 2023)

Unit Purchase Agreement between Marizyme, Inc. and the investors identified on Appendix A thereto, dated as of November 20, 2023 (Filed With SEC on November 21, 2023)

Unit Purchase Agreement between Marizyme, Inc. and the investors identified on Appendix A thereto, dated as of August 30, 2023 (Filed With SEC on September 5, 2023)

Unit Purchase Agreement between Marizyme, Inc. and the investor identified on Appendix A thereto, dated July 10, 2023 (Filed With SEC on July 12, 2023)

Unit Purchase Agreement between Marizyme, Inc. and each investor identified on Appendix A thereto, dated as of May 30, 2022 (Filed With SEC on June 5, 2023)

Unit Purchase Agreement between Marizyme, Inc. and each investor identified on Appendix A thereto (Filed With SEC on May 18, 2023)

Securities Purchase Agreement, dated as of February 6, 2023, by and between Marizyme, Inc. and Walleye Opportunities Master Fund Ltd (Filed With SEC on February 7, 2023)

Form of Unit Purchase Agreement between Marizyme, Inc. and the investors signatory thereto (Filed With SEC on December 27, 2021)

Form of Unit Purchase Agreement, dated May 2021 (Filed With SEC on August 23, 2021)

AMENDMENT NO. 3 TO ASSET PURCHASE AGREEMENT DATED DECEMBER 15, 2019 (Filed With SEC on August 5, 2020)

AMENDMENT 2 to the ASSET PURCHASE AGREEMENT Dated May 29, 2020 (Filed With SEC on June 5, 2020)

AMENDMENT 1 to the ASSET PURCHASE AGREEMENT Dated December 15, 2019 (Filed With SEC on June 5, 2020)

ASSET PURCHASE AGREEMENT (Filed With SEC on December 19, 2019)

Asset Purchase Agreement, dated April 26, 2010, between SWAV Enterprises Ltd. and Lotus Holdings Limited (Filed With SEC on April 26, 2010)